Evidence map›Paper›PMID 40959584›Full record

ArticleJournal of clinical research in pediatric endocrinology2026

X-linked Osteoporosis due to PLS3 Pathogenic Variant: Case Report on Zoledronic Acid Treatment in Siblings

María Camila Velandia-Avendaño, María Paula Sarmiento-Ramón

Abstract readCase Reports
In one paragraph

Article in Journal of clinical research in pediatric endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

María Camila Velandia-AvendañoPediatric Resident, Universidad Industrial de Santander, Bucaramanga, ColombiaORCID 0000-0002-9809-0993
María Paula Sarmiento-RamónPediatric Endocrinologist, Fundación Oftalmológica de Santander, Floridablanca, ColombiaORCID 0000-0002-4286-2114

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis in children is a rare condition, often associated with genetic factors. Monogenic forms of osteoporosis linked to the X chromosome are often related to mutations in the gene encoding plastin 3 (PLS3). PLS3 is a protein involved in actin bundle formation in the cytoskeleton. We present two brothers with recurrent peripheral fractures and vertebral compression fractures, both associated with low bone mineral density (BMD). The patients shared the same deletion (c.589_590) in

Indexed as

Bone Density Conservation AgentsGenetic Diseases, X-LinkedMembrane GlycoproteinsMicrofilament ProteinsOsteoporosisZoledronic AcidBone DensityChildHumansMaleSiblingsBone Density Conservation AgentsMembrane GlycoproteinsMicrofilament ProteinsplastinZoledronic AcidBone diseasesJuvenile osteoporosisPLS3Zoledronic acid

Identifiers

PMID40959584
PMCPMC13554932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.